Skip to main content
. 2015 Sep 7;24(22):6350–6360. doi: 10.1093/hmg/ddv344

Table 1.

Clinical cases with mutations identified in NDUFV1 and comparison with effects in Y. lipolytica

Mutation(s) Zygosity Clinical reporta References Effects in Y. lipolytica
S56P+T423M Compound heterozygous Leuko-encephalopathy (alive at 2.5 years) (7) Not conserved+ complex I absent
R88G+R199P Compound heterozygous Fatal infantile lactic acidosis (died 4 months) (24) Complex I absent+ normal
K111E+R386H Compound heterozygous Not known (25) Not conserved+ impaired
A117T+E246K Compound heterozygous Fatal infantile lactic acidosis (died 3 days) (26) Complex I absent+ complex I absent
R147W mtDNA Heterozygous+mtDNA Not known (25) Normal +not studied
Y204C+C206G Compound heterozygous Leigh syndrome (alive at 7 years) (27,28) Complex I absent+ no flavin
A211V+R257Q Compound heterozygous Leuko-encephalopathy (alive at 16 months) (29) Not conserved+ complex I absent
E214K Compound heterozygous; second variant not expressed owing to mutation in donor splice-site Leigh syndrome
(died 3 years)
(28) Impaired
P252R+R386H Compound heterozygous Not known (25) Complex I absent+ impaired
A341V Homozygous Leuko-encephalopathy (alive at 10 years) (30) Normal
E377K Homozygous Fatal infantile lactic acidosis (died 4 months) (25) No flavin
R386C Homozygous Leuko-encephalopathy (alive at 32 months) (24,31) Impaired
R386H Homozygous Leigh syndrome (died 5–8 months) (32) Impaired
T423M+R59X Compound heterozygous; R59X variant not expressed Myoclonic epilepsy (died 18 months) (30) Complex I absent
A432P Compound heterozygous; second variant not expressed owing to two base deletion Leigh syndrome (died 1.5 years) (28) Impaired

aA detailed summary of clinical data is presented in Supplementary Material, Table S1.